Apellis Pharmaceuticals Inc (APLS)
42.57
+0.27
(+0.64%)
USD |
NASDAQ |
May 09, 16:00
42.41
-0.16
(-0.38%)
After-Hours: 20:00
Apellis Pharmaceuticals Profit Margin (Quarterly): -38.55% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -38.55% |
December 31, 2023 | -60.51% |
September 30, 2023 | -127.0% |
June 30, 2023 | -128.5% |
March 31, 2023 | -396.4% |
December 31, 2022 | -732.4% |
September 30, 2022 | -867.2% |
June 30, 2022 | -955.6% |
Date | Value |
---|---|
March 31, 2022 | -966.1% |
December 31, 2021 | -245.4% |
September 30, 2021 | -3.46K% |
June 30, 2021 | -35.18K% |
March 31, 2021 | |
December 31, 2020 | 31.31% |
September 30, 2020 | -21.01K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-35.18K%
Minimum
Jun 2021
31.31%
Maximum
Dec 2020
-4.58K%
Average
-564.4%
Median
Profit Margin (Quarterly) Benchmarks
Blueprint Medicines Corp | 92.74% |
Sarepta Therapeutics Inc | 8.74% |
Alnylam Pharmaceuticals Inc | -13.34% |
Ionis Pharmaceuticals Inc | -119.5% |
Madrigal Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -143.8% |
Return on Assets | -48.15% |
Return on Invested Capital | -108.9% |
Gross Profit Margin (Quarterly) | 88.27% |
Operating Margin (Quarterly) | -36.03% |
Return on Net Operating Assets | -119.7% |